Drug safety articles within Nature

Featured

• Article | 27 May 2021

  BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

  In a phase-I/II trial in healthy adults, the BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells against SARS-CoV-2 epitopes that are conserved in a wide range of currently circulating variants.

  • Ugur Sahin
  • , Alexander Muik
  •  & Özlem Türeci

• Brief Communications Arising | 17 September 2014

  GATM locus does not replicate in rhabdomyolysis study

  • James S. Floyd
  • , Joshua C. Bis
  •  & Bruce M. Psaty

• Outlook | 26 June 2013

  Drug safety: Double jeopardy

  Leukaemia in children is highly curable, but many survivors suffer severe, even life-threatening, long-term effects. Scientists are seeking ways to deliver a safer cure.

  • Mary Carmichael

• News | 31 August 2012

  Doctors debate safety of starch drips

  Study fuels controversy over widely used intravenous fluids.

  • Daniel Cressey

• News & Views | 10 June 2012

  Computer model predicts side effects

  Drug candidates are usually found to be unsafe only late in the drug discovery process. A method for predicting the many biological targets of a given molecule might allow drug safety to be considered much earlier. See Article p.361

  • Kyle Kolaja

• News | 14 March 2012

  Drug data reveal sneaky side effects

  Mining of surveillance data highlights thousands of previously unknown consequences when drugs are taken together.

  • Heidi Ledford

• News | 07 October 2010

  European research animal use holds steady

  The use of transgenic mice is on the rise, along with non-animal alternatives.

  • Alison Abbott

• News | 03 August 2010

  Drug safety crackdown revs up

  FDA's strengthened powers to assess drugs already on the market will soon be put to the test.

  • Heidi Ledford